Akt1 is a serine-threonine kinase that relays signals from phosphatidylinositol 3′ kinase (PI3K) by its phosphorylation of downstream targets and deregulation of this pathway is known to contribute to prostate cancer progression [25], [26]. Here, MARK2 is linked to Familial prostate cancer.